Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods

Figure 1

Contribution of AdnaTest markers to circulating tumour cell (CTC) positivity. The contribution of EPCAM, MUC1, ERBB2 and of all their combinations to CTC positivity is reported for and cases at each time point analyzed (baseline, ; after first, ; and second, , cycle of therapy). Numbers within the bars refer to the number of CTC-positive samples expressing specific markers or their combinations as indicated by the colour code.